CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients
- 1 August 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 106 (3) , 1008-1011
- https://doi.org/10.1182/blood-2005-02-0607
Abstract
A proportion of cancer patients naturally develop CD4+ T-helper type 1 (Th1) cell responses to NY-ESO-1 that correlate with anti-NY-ESO-1 serum antibodies. To address the role of T-cell regulation in the control of spontaneous tumor immunity, we analyzed NY-ESO-1-specific Th1 cell induction before or after depletion of CD4+CD25+ T cells in vitro. While Th1 cells were generated in the presence of CD25+ T cells in cancer patients seropositive for NY-ESO-1, seronegative cancer patients and healthy donors required CD25+ T-cell depletion for in vitro induction of NY-ESO-1-specific Th1 cells. In vitro, newly generated NY-ESO-1-specific Th1 cells were derived from naive precursors, whereas preexisting memory populations were detectable exclusively in patients with NY-ESO-1 antibody. Memory populations were less sensitive than naive populations to CD4+CD25+ regulatory T cells. We propose that CD4+CD25+ regulatory T cells are involved in the generation and regulation of NY-ESO-1-specific antitumor immunity.Keywords
This publication has 22 references indexed in Scilit:
- Definition of target antigens for naturally occurring CD4+ CD25+ regulatory T cellsThe Journal of Experimental Medicine, 2005
- Toll-Dependent Control Mechanisms of CD4 T Cell ActivationImmunity, 2004
- Identification of a CD4+CD25+ T?cell subset committedin vivoto suppress antigen-specific T?cell responses without additional stimulationEuropean Journal of Immunology, 2004
- Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survivalNature Medicine, 2004
- Persistent Toll-like receptor signals are required for reversal of regulatory T cell–mediated CD8 toleranceNature Immunology, 2004
- NaturallyArisingCD4+RegulatoryT Cells forImmunologicSelf-Tolerance andNegativeControl ofImmuneResponsesAnnual Review of Immunology, 2004
- Tumor-Specific Human CD4+ Regulatory T Cells and Their LigandsImmunity, 2004
- CD4+CD25+T cells responding to serologically defined autoantigens suppress antitumor immune responsesProceedings of the National Academy of Sciences, 2003
- Survey of naturally occurring CD4 + T cell responses against NY-ESO-1 in cancer patients: Correlation with antibody responsesProceedings of the National Academy of Sciences, 2003
- A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screeningProceedings of the National Academy of Sciences, 1997